IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Great Point Partners LLC

Q1 2022 Holdings

Filed 2022-05-16 | 30 holdings | $73.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Bicycle Therapeutics PLC(BCYC)SPONSORED ADS088786108$24.2M550,59232.9%
Cytokinetics Inc(CYTK)COM NEW23282W605$23.9M650,00032.6%
Aclaris Therapeutics Inc(ACRS)COM00461U105$16.2M942,44522.1%
Ardelyx Inc(ARDX)COM039697107$5.1M4,761,9056.9%
Acumen Pharmaceuticals Inc(ABOS)COM00509G209$3.6M928,2824.9%
Exelixis Inc(EXEL)COM30161Q104$29.5K1,300,0000.0%
Xenon Pharmaceuticals Inc(XENE)COM98420N105$28.1K920,0000.0%
Travere Therapeutics Inc(TVTX)COM89422G107$26.0K1,010,0000.0%
Jazz Pharmaceuticals PLC(JAZZ)SHS USDG50871105$24.1K155,0000.0%
Chinook Therapeutics Inc(290A)COM16961L106$23.3K1,423,6820.0%
Galapagos NV(GLPG)SPON ADR36315X101$22.3K360,0000.0%
Vertex Pharmaceuticals Inc(VRTX)COM92532F100$22.2K85,0000.0%
Vaxcyte Inc(PCVX)COM92243G108$21.4K885,1530.0%
Relmada Therapeutics Inc(RLMD)COM75955J402$21.3K790,0000.0%
Anaptysbio Inc(ANAB)COM032724106$17.3K700,0000.0%
Point Biopharma Global IncCOM730541109$16.4K2,060,0000.0%
Kalvista Pharmaceuticals Inc(KALV)COM483497103$12.9K874,1970.0%
Rigel Pharmaceuticals Inc(RIGLUSD)COM NEW766559603$12.0K4,000,0000.0%
Kiniksa Pharmaceuticals LTDCOM CL AG5269C101$11.1K1,118,0670.0%
Tricida Inc(1T7)COM89610F101$10.3K1,250,0000.0%
Avidity Biosciences Inc(RNA)COM05370A108$9.2K500,0000.0%
Silence Therapeutics PLC(SLN)ADS82686Q101$8.4K444,4430.0%
Urogen Pharma LTD(URGN)COMM96088105$7.6K873,4240.0%
Pieris Pharmaceuticals IncCOM720795103$6.7K2,199,0760.0%
Ventyx Biosciences Inc(VTYX)COM92332V107$4.6K336,3340.0%
Magenta Therapeutics IncCOM55910K108$3.4K1,170,0000.0%
Cincor Pharma IncCOM17240Y109$1.4K79,6700.0%
Nektar Therapeutics(NKTREUR)CallCOM640268108$539100,0000.0%
Passage BIO IncCOM702712100$353113,9000.0%
Rafael Hldgs Inc(RFL)COM CL B75062E106$304121,0000.0%